<html lang="en">
	<meta http-equiv='cache-control' content='no-cache'> 
	<meta http-equiv='expires' content='0'> 
	<meta http-equiv='pragma' content='no-cache'>
<head>
	<meta charset="UTF-8">
	<meta name="viewport" content="width=device-width, initial-scale=1.0">
	<title>MVT <i>in</i> Silico Corp., London Canada.</title>
	<link rel="stylesheet" href="styles.css">
</head>
<body>
	<center><h4><bold>These pages adopt a KISS principle and are best seen in a desktop or laptop brower.</bold></h4></center>
	<img src="mvtISLogo_September2024.png" witdth="300px" height="70"  class="centerImage" alt="MVTISLogo">
	<center><h1>MVT <i>in</i> Silico Corp.</h1></center>
	<h1>01.</h1>
	<h2>Strap Line.</h2>
	We are MVT <i>in</i> Silico who deploy fundamental scientific principles to build effective medical treatments.
	<h1>02.</h1>
	<h2>About Us.</h2>
	MVTIS is a life sciences company that presently provides CM&S services for the life sciences. 
	We provide evidence for products that our clients wish to patent. We encompass a wide range of capabilities from 
	molecular drug-enzyme interactions to whole body blood flow circulation.
	<h1>03.</h1>
	<h2> The Challenge.</h2>
	There is a high failure rate in the development of medical treatments from discovery stage to market.
	A major reason for this is our lack of understanding of the system that the treatment is intended to treat.
	<h1>04.</h1>
	<h2>The Solution.</h2>
	We use computer modelling & simulation to understand the system that the treatment is intended to treat.
	To do so, we have developed our proprietary software called "MVT Software Suite." that has modules that are 
	capable of simulating the system from the molecular level to the whole body level to digital clinical trials.
	<h1>05.</h1>
	<h2>Vision</h2>
	Reduce the burden of critical illness treatments through a computer modelling & simulation (CM&S) first approach,
	and become a manufacturer of medical treatments.
	<h1>06.</h1>


	<h2>Partners & Funders.</h2>
	<h2>Products & Pipelines.</h2>
	<h2>Projects</h2>
	<h2>Team</h2>
	<li>President, CEO, and Chief Science Officer. (founder)</li>
	<li>Pharmacology advisor.</li>
	<li>CFD advisor.</li>
	<li>Lawyer.</li>
	<h2>Contact</h2>
	<li>Phone: 5198780685 </li>
	<li>Email: sumus@mvtinsilico.ca </li>
	<li>Address: London, Ontario. </li>
	<li>LinkedIn:  </li>

	<h2>Terms of Use and Privacy Policy.</h2>

<p>Copyright. 2025. MVT <i>in</i> Silico Corp. All rights reserved.</p>
</body>
</html>